Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2023
Comprehensive Genomic and Transcriptomic Analysis of Sclerosing PneumocytomaYi-Chen Yeh, Ping-Yuan Chu, Shin-Ying Lin, et al.The American Journal of Surgical Pathology|October 19, 2018
Epstein-Barr Virus-Associated Pulmonary Carcinoma: Proposing an Alternative Term and Expanding the Histologic Spectrum of Lymphoepithelioma-like Carcinoma of the LungYi-Chen Yeh, Hua-Lin Kao, Kang-Lung Lee, et al.Journal of the Chinese Medical Association : JCMA|November 12, 2020
Establishing diagnostic algorithms for SARS-CoV-2 nucleic acid testing in clinical practiceHsiang-Ling Ho, Yen-Yu Lin, Fang-Yu Wang, et al.Cancer Cytopathology|September 25, 2020
Programmed death-ligand 1 (PD-L1)/thyroid transcription factor-1 double immunohistochemical staining facilitates scoring of tumor PD-L1 expression in cytopathology specimens from lung adenocarcinoma patientsYen-Yu Lin, Li-Ya Lin, Jen-Fan Hang, et al.Journal of Cancer Research and Clinical Oncology|May 27, 2019
PD-L1 is a double-edged sword in colorectal cancer: the prognostic value of PD-L1 depends on the cell type expressing PD-L1Hsiang-Ling Ho, Teh-Ying Chou, Shung-Haur Yang, et al.Oncotarget|April 1, 2015
MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinomaChao-Hua Chiu, Hsiang-Ling Ho, Howard Doong, et al.Pathology|March 28, 2025
Frequent PIK3CA and GNAQ mutations in solitary pulmonary capillary haemangioma and pulmonary cavernous haemangioma: genetic link to vascular malformationsYi-Chen Yeh, Ping-Yuan Chu, Chia-I Lin, et al.Oncotarget|August 21, 2018
High O-linked N-acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinomaYi-Cheng Lin, Chia-Hung Lin, Yi-Chen Yeh, et al.The American Journal of Surgical Pathology|September 26, 2017
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better PrognosisYi-Chen Yeh, Hao-Jan Lei, Ming-Huang Chen, et al.Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methodsHua-Lin Kao, Yi-Chen Yeh, Chin-Hsuan Lin, et al.Pageof 7